Cureus scoping review examines GLP-1 agonists in polycystic ovary syndrome

The wire

1. 01The scoping review in Cureus collects published evidence on reproductive and gynecologic outcomes among women with PCOS treated with GLP-1 receptor agonists.
2. 02PCOS is a common off-label reason clinicians reach for incretins, so a mapped evidence base is useful for counseling on fertility and menstrual effects.
3. 03Scoping reviews describe rather than pool the literature, and no effect sizes or trial details are available from the listing.

From the source

Reproductive and Gynecologic Effects of Glucagon-Like Peptide-1 Receptor Agonists in Women With Polycystic Ovary Syndrome: A Scoping Review